Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
23.82
+0.82 (+3.57%)
Streaming Delayed Price
Updated: 10:26 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intellia Thera CS
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Why Editas Medicine Stock Is Jumping Today
June 28, 2021
Good news for Intellia was viewed as good news for Editas.
Via
The Motley Fool
44 Stocks Moving In Monday's Mid-Day Session
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...
Via
Benzinga
Why Intellia Therapeutics Stock Is Skyrocketing Today
June 28, 2021
The company reported promising interim trial results for its CRISPR gene-editing candidate.
Via
The Motley Fool
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Intellia Stock Leads Biotech Rally On Historic Moment For CRISPR
June 28, 2021
Intellia led a rally for CRISPR stocks on Monday on early promise for its gene-editing drug. The news sent NTLA stock to a record high.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Monday
June 28, 2021
During the morning session on Monday, 118 stocks hit new 52-week highs. Highlights: The company with the largest market cap to set a new 52-week high was Microsoft...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook
June 28, 2021
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Intellia Therapeutics Stock Is Soaring Today
June 28, 2021
Intellia Therapeutics Inc (NASDAQ:NTLA) is trading signifi...
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 28, 2021
Barclays raised the price target for Accenture plc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion....
Via
Benzinga
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
June 28, 2021
Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics.
Via
InvestorPlace
24 Stocks Moving in Monday's Pre-Market Session
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim...
Via
Benzinga
Intellia Shares Shoot Higher On Promising Biomarker Data From CRISPR/Cas9 Genome Editing Candidate
June 28, 2021
Intellia Therapeutics Inc (NASDAQ: NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have announced positive interim data from an ongoing Phase 1...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower
June 28, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged more than 230 points in the previous session. The S&P 500 index also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Expert Ratings For Intellia Therapeutics
June 23, 2021
Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1...
Via
Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
What's the Best Way to Invest in Genetics Stocks?
June 07, 2021
Here are some of our experts' favorite gene editing plays for the long run.
Via
The Motley Fool
This Genetics Stock Could Have a Bright Future
June 03, 2021
Here's one genetics play that you might want to put on your radar.
Via
The Motley Fool
Biotech Stocks Cruise Through The Volatility
May 25, 2021
The XLV Healthcare Select SPDR is up 10% YTD.
Via
Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 14, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Intellia Therapeutics, Inc. (NTLA) Q1 2021 Earnings Call Transcript
May 07, 2021
NTLA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021
May 07, 2021
Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
May 04, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
3 Exciting Biotech Stocks to Buy Right Now
April 30, 2021
Gene therapies could be poised to enter an era of extraordinarily rapid advancement.
Via
The Motley Fool
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
April 16, 2021
A "sell" rating is one thing, but a 50% price target? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it.
Via
InvestorPlace
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
April 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.